Maaike W. van de Kamp

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial

Jeroen van Dorp, Christodoulos Pipinikas, Britt B.M. Suelmann et al. · Nature Medicine · 2023 · 78 citations · Full text

Medicine, Oncology, Urology +10

Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy

Francesco Claps, Maaike W. van de Kamp, Roman Mayr et al. · British Journal of Urology · 2023 · 61 citations · Full text

Medicine, Oncology, Surgery +17

Risk factors associated with positive surgical margins’ location at radical cystectomy and their impact on bladder cancer survival

Francesco Claps, Maaike W. van de Kamp, Roman Mayr et al. · World Journal of Urology · 2021 · 45 citations · Full text

Medicine, Surgery, Urology +14

Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: A convenient alternative to 5-fluorouracil

Charlotte S. Voskuilen, Maaike W. van de Kamp, Nannet Schuring et al. · Radiotherapy and Oncology · 2020 · 14 citations

Medicine, Oncology, Pharmacology +16

Survival after neoadjuvant/induction combination immunotherapy vs combination platinum‐based chemotherapy for locally advanced (Stage <scp>III</scp>) urothelial cancer

Sarah Einerhand, Nick van Dijk, Jeroen van Dorp et al. · International Journal of Cancer · 2022 · 14 citations · Full text

Medicine, Oncology, Urology +17